Details of the Drug

General Information of Drug (ID: DMJUJW9)

Drug Name
AR20.5
Indication
Disease Entry ICD 11 Status REF
Pancreatic cancer 2C10 Phase 1/2 [1]
Cross-matching ID
TTD ID
D07PCZ

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)